(Q40915870)

English

Immunosuppressant FK506 activates NF-kappaB through the proteasome-mediated degradation of IkappaBalpha. Requirement for Ikappabalpha n-terminal phosphorylation but not ubiquitination sites

scientific article

Statements

Immunosuppressant FK506 activates NF-kappaB through the proteasome-mediated degradation of IkappaBalpha. Requirement for Ikappabalpha n-terminal phosphorylation but not ubiquitination sites (English)
1 December 1999
34657-34662

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit